Biocom CFO Presents: Investor Relations – A Critical CFO and Board Priority
Research shows that an effective investor relations program can account for a 30% variance in a company’s valuation. Investor communications is a vital function at any publicly traded company, and an active agenda topic at board meetings. We’ve assembled CFO’s and board members to share their perspective on key investor relations topics that matter to...